Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 1/2022

Open Access 01-01-2022 | Anemia | Letter to the Editor

Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah’s Witness patient

Authors: Sebastian Schlaweck, Peter Brossart, Annkristin Heine

Published in: Annals of Hematology | Issue 1/2022

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Maitre E, Cornet E, Troussard X (2019) Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment. Am J Hematol. 94(12):1413–1422CrossRef
2.
Tiacci E, Trifonov V, Schiavoni G, Holmes A, Kern W, Martelli MP (2011) u. a. BRAF mutations in hairy-cell leukemia. N Engl J Med 364(24):2305–2315CrossRef
3.
Andrasiak I, Rybka J, Wrobel T (2018) Response to the therapy in hairy cell leukemia: systematic review and meta-analysis. Clin Lymphoma Myeloma Leuk 18(6):392–399.e3CrossRef
Metadata
Title
Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah’s Witness patient
Authors
Sebastian Schlaweck
Peter Brossart
Annkristin Heine
Publication date
01-01-2022
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 1/2022
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-021-04403-4

Other articles of this Issue 1/2022

Annals of Hematology 1/2022 Go to the issue

Letter to the Editor

The first case of a collision tumor of gastrointestinal stromal tumor and intravascular large B cell lymphoma

Letter to the Editor

HSV1 viremia with fulminant hepatitis as opportunistic sequela in severe COVID-19

Original Article

Characterization of molecular genetics and clinicopathology in thymic MALT lymphoma

Letter to the Editor

Clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma: a single-institute retrospective study

Letter to the Editor

Morbidity-free survival and hemoglobin level in non-transfusion-dependent β-thalassemia: a 10-year cohort study

Original Article

Analysis of incidence and risk factors of the multidrug resistant gastrointestinal tract infection in children and adolescents undergoing allogeneic and autologous hematopoietic cell transplantation: a nationwide study

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits